Hosted on MSN
What Is Metastatic Cancer? How It Spreads, What It Means And Why Chemotherapy Isn’t Always Enough
Many cancers can often be treated successfully when detected early. Surgery, radiation and chemotherapy are all powerful tools to remove or destroy tumors in their original location. However, when ...
What Is Metastatic Throat Cancer? It’s cancer that starts in your throat and spreads to other parts of your body. Your doctor may call it stage IV or advanced throat cancer. Most throat cancers are ...
Add Yahoo as a preferred source to see more of our stories on Google. And now, a new study published in Nature has found that viral lung infections can awaken dormant breast cancer cells that have ...
An ipsilateral breast cancer recurrence after long disease-free interval may still permit curative-intent local therapy, with ...
Women with de novo metastatic breast cancer that is confined to a single distant organ may live longer when they undergo resection of the primary tumor, a large cohort study suggested. The study, of ...
What to know about the fatigue, anxiety and brain fog that can accompany your diagnosis getty When people think about breast cancer symptoms, they often think of a lump in the breast or in the ...
But it doesn't always end there. At some point, you may need to switch treatments. The growing number of options to manage HR-positive/HER2-negative metastatic breast ...
A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.
Navigating a metastatic castration-resistant prostate cancer (mCRPC) diagnosis while preserving self-identity can feel like wandering through a foggy wilderness, quiet and cautious, afraid that any ...
DNA MRD monitoring offers new clues for stopping chemo safely in metastatic gastroesophageal cancer, linking molecular response to outcomes. In an interview with Targeted Oncology, Rutika Mehta, MD, ...
PATINA supports adding palbociclib to anti-HER2 plus endocrine therapy in HR+/HER2+ disease, and HER2CLIMB-05 validates tucatinib with HP after THP induction. Sequencing trials must address ADC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results